source
- FDA officials share guidance on de novo device classifications and upcoming MDUFA VI changes at MedTech ConferenceAt the MedTech Conference in Boston, FDA officials and industry experts discussed de novo classification requests. They offered practical tips for companies seeking de novo designation, stressing…
- Boehringer Ingelheim and Microsoft launch AI partnership to develop digital patient twins for clinical trialsBoehringer Ingelheim and Microsoft announced a collaboration to investigate AI driven digital patient twins that model individual patients for clinical trial design. The work will explore disease…